Ignite Creation Date:
2024-05-06 @ 12:11 AM
Last Modification Date:
2024-10-26 @ 10:46 AM
Study NCT ID:
NCT01514864
Status:
TERMINATED
Last Update Posted:
2023-12-19
First Post:
2012-01-18
Brief Title:
Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2014-07-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07-23
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-18
First Submit QC Date:
January 20 2012
Study First Post Date:
2012-01-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-12-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-17
Last Update Post Date:
2023-12-19
Last Update Post Date Type:
ACTUAL